Skip to Main Content

Paper Details

Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndrome.
Cytotherapy
7
2021
Author NameAffiliation
Rafael BejarUniversity of California San Diego Moores Cancer Center
  • 1 - 1

Datasets

Release 1.2